Sign in
4

Changes in Ownership

Atara Biotherapeutics, Inc. Filed Acc 0001209191-19-033638

Chief Executive Officer sold 5,850 shares at an average $23.09 ($135,089)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Ciechanover Isaac E. Chief Executive Officer 2019-05-29 Sale −2,200 $22.85 $50,270 294,337 I: show line 1 in the form
Ciechanover Isaac E. Chief Executive Officer 2019-05-29 Sale −725 $23.30 $16,893 293,612 I: show line 2 in the form
Ciechanover Isaac E. Chief Executive Officer 2019-05-30 Sale −1,425 $22.72 $32,376 292,187 I: show line 3 in the form
Ciechanover Isaac E. Chief Executive Officer 2019-05-30 Sale −1,500 $23.70 $35,550 290,687 I: show line 4 in the form
Open-market sales · 5,850 sh · avg $23.09 · $135,089
Loading xslF345X03/doc4.xml…